TipRanks
Universal Ibogaine Inc (DE:JC4)
FRANKFURT:JC4
Germany Market
JC4
Universal Ibogaine Inc
RESEARCH TOOLSreports

Universal Ibogaine Inc (JC4) Ratios

1 Followers

Universal Ibogaine Inc Ratios

DE:JC4's free cash flow for Q3 2025 was C$0.25. For the 2025 fiscal year, DE:JC4's free cash flow was decreased by C$ and operating cash flow was C$-0.04. See a summary of the company’s cash flow.
Ratios
TTM
Jan 25Jul 23Oct 22Jul 21
Liquidity Ratios
Current Ratio
 1.04 ― ― 1.60 0.91
Quick Ratio
 1.04 ― ― 1.60 0.91
Cash Ratio
 0.37 ― ― 1.14 0.14
Solvency Ratio
 -0.48 ― ― -4.31 -3.62
Operating Cash Flow Ratio
 -0.84 ― ― -6.80 -3.29
Short-Term Operating Cash Flow Coverage
 -7.87 ― ― 0.00 -9.28
Net Current Asset Value
C$ -2.48MC$ ―C$ ―C$ -1.36MC$ -146.33K
Leverage Ratios
Debt-to-Assets Ratio
 0.59 ― ― 0.28 0.10
Debt-to-Equity Ratio
 2.68 ― ― 0.44 0.14
Debt-to-Capital Ratio
 0.73 ― ― 0.31 0.12
Long-Term Debt-to-Capital Ratio
 0.71 ― ― 0.31 0.02
Financial Leverage Ratio
 4.55 ― ― 1.60 1.36
Debt Service Coverage Ratio
 -5.59 ― ― -67.13 -10.35
Interest Coverage Ratio
 3.27 ― ― 7.34 -255.45
Debt to Market Cap
 1.65 ― ― 0.27 0.02
Interest Debt Per Share
 0.01 ― ― <0.01 <0.01
Net Debt to EBITDA
 -1.48 ― ― -0.22 -0.07
Profitability Margins
Gross Profit Margin
100.00%――100.00%0.00%
EBIT Margin
-80.76%――0.00%0.00%
EBITDA Margin
-66.03%――-430.27%0.00%
Operating Profit Margin
23.67%――46.43%0.00%
Pretax Profit Margin
-88.01%――-980.22%0.00%
Net Profit Margin
-88.01%――-980.22%0.00%
Continuous Operations Profit Margin
-88.01%――0.00%0.00%
Net Income Per EBT
100.00%――100.00%100.00%
EBT Per EBIT
-371.89%――-2111.27%100.89%
Return on Assets (ROA)
-45.46%――-166.14%-96.88%
Return on Equity (ROE)
-149.60%――-266.20%-131.36%
Return on Capital Employed (ROCE)
15.69%――8.75%-127.60%
Return on Invested Capital (ROIC)
15.14%――8.70%-114.29%
Return on Tangible Assets
-45.46%――-166.14%-96.88%
Earnings Yield
-176.48%――-161.55%-19.31%
Efficiency Ratios
Receivables Turnover
 12.00 ― ― 4.64 0.00
Payables Turnover
 0.00 ― ― 0.00 0.00
Inventory Turnover
 0.00 ― ― 0.00 0.00
Fixed Asset Turnover
 0.67 ― ― 0.20 0.00
Asset Turnover
 0.52 ― ― 0.17 0.00
Working Capital Turnover Ratio
 -2.03 ― ― 7.30 0.00
Cash Conversion Cycle
 30.42 ― ― 78.74 0.00
Days of Sales Outstanding
 30.42 ― ― 78.74 0.00
Days of Inventory Outstanding
 0.00 ― ― 0.00 0.00
Days of Payables Outstanding
 0.00 ― ― 0.00 0.00
Operating Cycle
 30.42 ― ― 78.74 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 ― ― -0.02 -0.03
Free Cash Flow Per Share
 >-0.01 ― ― -0.02 -0.03
CapEx Per Share
 <0.01 ― ― <0.01 0.00
Free Cash Flow to Operating Cash Flow
 1.09 ― ― 1.02 1.00
Dividend Paid and CapEx Coverage Ratio
 -10.68 ― ― -45.29 -7.93
Capital Expenditure Coverage Ratio
 -10.68 ― ― -45.29 0.00
Operating Cash Flow Coverage Ratio
 -0.32 ― ― -2.49 -7.93
Operating Cash Flow to Sales Ratio
 -0.36 ― ― -4.05 0.00
Free Cash Flow Yield
-58.63%――-68.16%-16.22%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.50 ― ― -0.62 -5.18
Price-to-Sales (P/S) Ratio
 0.67 ― ― 6.07 0.00
Price-to-Book (P/B) Ratio
 1.17 ― ― 1.65 6.80
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.71 ― ― -1.47 -6.16
Price-to-Operating Cash Flow Ratio
 -1.39 ― ― -1.50 -6.16
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 ― ― >-0.01 -0.02
Price-to-Fair Value
 1.17 ― ― 1.65 6.80
Enterprise Value Multiple
 -2.50 ― ― -1.63 -5.39
Enterprise Value
 3.85M ― ― 7.51M 20.30M
EV to EBITDA
 -2.50 ― ― -1.63 -5.39
EV to Sales
 1.65 ― ― 7.01 0.00
EV to Free Cash Flow
 -4.19 ― ― -1.70 -6.25
EV to Operating Cash Flow
 -4.59 ― ― -1.73 -6.25
Tangible Book Value Per Share
 <0.01 ― ― 0.02 0.02
Shareholders’ Equity Per Share
 <0.01 ― ― 0.02 0.02
Tax and Other Ratios
Effective Tax Rate
 0.00 ― ― <0.01 >-0.01
Revenue Per Share
 0.01 ― ― <0.01 0.00
Net Income Per Share
 >-0.01 ― ― -0.06 -0.03
Tax Burden
 1.00 ― ― 1.00 1.00
Interest Burden
 1.09 ― ― 0.00 1.01
Research & Development to Revenue
 0.04 ― ― 0.38 0.00
SG&A to Revenue
 0.44 ― ― 4.27 0.00
Stock-Based Compensation to Revenue
 >-0.01 ― ― 0.84 0.00
Income Quality
 0.41 ― ― 0.41 0.84
Currency in CAD